A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for BridgeBio Pharma LLC.

Business address: C/O Bridgebio Pharma, Inc., 3160 Porter Drive, Suite 250, Palo Alto, CA, 94304
Top holdings (ownership): BBOT
Top holdings (Schedule 13D): HLXB
State of incorporation: DE
Fiscal year end: 31 December

Get insider transactions for this reporting owner

BridgeBio Pharma LLC has filed 3 SEC EDGAR filings since 18 Aug 2025

Recent SEC filings for BridgeBio Pharma LLC including 4, SCHEDULE 13D, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	16 Oct 2025	10 Oct 2025	001-41955
SCHEDULE 13D	Open SCHEDULE 13D document	View SEC filing for SCHEDULE 13D		18 Aug 2025
3	Open 3 document	View SEC filing for 3	3	18 Aug 2025	11 Aug 2025	001-41955

BridgeBio Pharma LLC files with the SEC under CIK 0002076615. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.